Ivonescimab Beat Imfinzi Regimen on Survival in China Bile Duct Cancer Trial, Akeso Says, as Details Await ESMO
Akeso says ivonescimab plus chemo improved survival over Imfinzi plus chemo in advanced biliary tract cancer in China. Full data will be presented at ESMO on Oct. 25.
Medical Daily ·